Neuralink said on social media that it received FDA breakthrough device designation for treating individuals with severe ...

Synhale Therapeutics Inc. (Synhale), a virtual, clinical-stage biotech company committed to transforming Pulmonary Hypertension (PH), announced the acquisition of Telaglenastat (CB-839), the ...